Bliss GVS Pharma’s arm receives compliant certification from USFDA
7th Oct 2019

Bliss GVS Pharma’s 70% subsidiary -- Kremoint Pharma has received a compliant certification from the US Food and Drug Administration (USFDA) that was based on the inspection conducted at the company's facility located at M.I.D.C, Ambernath (East), Thane-District, during the period June 17, 2019-June 20, 2019.

Bliss GVS Pharma is engaged in the manufacture of a wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products.